JİNEKOLOJİK KANSERLERDE GÜNCEL TARAMA YAKLAŞIMLARI VE ERKEN TANI
Özet
Jinekolojik kanserlerde korunma, tarama ve erken tanı yaklaşımları kanser türüne göre farklılık göstermektedir. Serviks kanseri, kalıcı yüksek riskli insan papilloma virüsü enfeksiyonuyla yakından ilişkili olup HPV aşılaması ve organize tarama programları sayesinde büyük ölçüde önlenebilen bir kanser türüdür. HPV-DNA testi, güncel yaklaşımlarda serviks kanseri taramasında tercih edilen temel yöntemlerden biri olarak öne çıkmaktadır. Pozitif sonuçların HPV genotiplendirmesi, sitolojik değerlendirme, kolposkopi ve gerektiğinde biyopsi ile ileri değerlendirilmesi gerekmektedir. Türkiye’de 30–65 yaş arasındaki kadınlara beş yılda bir HPV-DNA testi uygulanmaktadır. Buna karşılık asemptomatik ve ortalama riskli kadınlarda over ve endometriyal kansere yönelik mortaliteyi azalttığı kanıtlanmış toplum tabanlı rutin tarama programı bulunmamaktadır. Bu kanserlerde erken tanının temelini bireysel ve ailesel risklerin değerlendirilmesi, uyarıcı belirtilerin tanınması ve semptomatik kadınların gecikmeden tanısal incelemeye yönlendirilmesi oluşturmaktadır. Over kanserinde kalıtsal yatkınlık, aile öyküsü, ileri yaş ve endometriozis; endometriyal kanserde ise obezite, progesteronla dengelenmemiş östrojen maruziyeti, kronik anovulasyon, tip 2 diabetes mellitus ve Lynch sendromu önemli risk faktörleri arasındadır. Ebeler ve sağlık çalışanları; risk değerlendirmesi, HPV aşı danışmanlığı, kadınların taramaya yönlendirilmesi, sonuçların izlenmesi, belirti farkındalığının artırılması ve gerekli sağlık hizmetlerine erişimin desteklenmesinde önemli sorumluluklar üstlenmektedir. Jinekolojik kanserlere bağlı hastalık ve ölüm yükünün azaltılabilmesi için kanıta dayalı korunma, tarama, erken tanı ve izlem yaklaşımlarının kadın merkezli ve bütüncül biçimde uygulanması gerekmektedir.
Anahtar Kelimeler: Jinekolojik Kanserler, Serviks Kanseri, Over Kanseri, Endometriyal Kanser, Hpv-Dna Testi, Tarama, Erken Tanı, Ebelik
Konu Alanı: Tıp -> Tıp (diğer) -> Kadın Hastalıkları ve Doğum
American College of Obstetricians and Gynecologists. (2026, April 16). ACOG publishes updated guidance on evaluation of postmenopausal bleeding. https://www.acog.org/news/news-releases/2026/04/acog-publishes-updated-guidance-evaluation-postmenopausal-bleeding
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 74(3), 229–263. https://doi.org/10.3322/caac.21834
Centers for Disease Control and Prevention. (2024a, September 12). Gynecologic cancers basics. https://www.cdc.gov/gynecologic-cancer/about/index.html
Centers for Disease Control and Prevention. (2024b). HPV vaccine recommendations. https://www.cdc.gov/hpv/hcp/vaccination-considerations/
Centers for Disease Control and Prevention. (2024c, September 5). Symptoms of gynecologic cancers. https://www.cdc.gov/gynecologic-cancer/symptoms/index.html
Centers for Disease Control and Prevention. (2025, February 26). Reducing risk for gynecologic cancers. https://www.cdc.gov/gynecologic-cancer/prevention/index.html
Cohen, P. A., Jhingran, A., Oaknin, A., & Denny, L. (2019). Cervical cancer. Lancet (London, England), 393(10167), 169–182. https://doi.org/10.1016/S0140-6736(18)32470-X
Kervella, L., Berveiller, P., Bourdillon, M., & Rousseau, A. (2020). Midwives' practices related to cervical cancer screening during pregnancy: A vignette-based study. Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives, 26, 100539. https://doi.org/10.1016/j.srhc.2020.100539
Malekzadeh, E., Nourizadeh, R., Farshbaf-Khalili, A., Mehrabi, E., & Hakimi, S. (2022). The effect of decision-aid-based counseling on cervical cancer screening behavior among women: An interventional study. Journal of education and health promotion, 11, 205. https://doi.org/10.4103/jehp.jehp_714_21
National Cancer Institute. (2015, December 23). Risk factors for cancer. https://www.cancer.gov/about-cancer/causes-prevention/risk
National Cancer Institute. (2024a). Cervical cancer screening. https://www.cancer.gov/types/cervical/screening
National Cancer Institute. (2024b). HPV and cancer. https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer
National Cancer Institute. (2024c). Cervical cancer treatment (PDQ®)–Health professional version. https://www.cancer.gov/types/cervical/hp/cervical-treatment-pdq
National Cancer Institute. (2024d). Cervical cancer diagnosis. https://www.cancer.gov/types/cervical/diagnosis
National Cancer Institute. (2025). Cancer prevention overview (PDQ®)–Patient version. https://www.cancer.gov/about-cancer/causes-prevention/patient-prevention-overview-pdq
National Cancer Institute. (2026). Human papillomavirus vaccine. https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet
Nelson, H. D., Cantor, A. G., Pappas, M., Blackie, K., Yu, Y., & Fu, R. (2025). Patient Navigation Services for Breast and Cervical Cancer Screening and Follow-Up: A Meta-Analysis. JAMA internal medicine, 185(8), 976–985. https://doi.org/10.1001/jamainternmed.2025.1590
Gül Öztaş, H., & Işik, K. (2025). The Effect of Cervical Cancer Education Given to Women in Turkey on Knowledge, Attitudes, and Health Beliefs: A Randomized Controlled Study. Public health nursing (Boston, Mass.), 42(1), 363–373. https://doi.org/10.1111/phn.13456
PDQ Screening and Prevention Editorial Board. (2025a). Endometrial cancer prevention (PDQ®)–Health professional version. National Cancer Institute. https://www.cancer.gov/types/uterine/hp/endometrial-prevention-pdq
PDQ Screening and Prevention Editorial Board. (2025b). Ovarian, fallopian tube, and primary peritoneal cancers screening (PDQ®)–Health professional version. National Cancer Institute. https://www.cancer.gov/types/ovarian/hp/ovarian-screening-pdq
PDQ Screening and Prevention Editorial Board. (2025c). Ovarian, fallopian tube, and primary peritoneal cancers prevention (PDQ®)–Health professional version. National Cancer Institute. https://www.cancer.gov/types/ovarian/hp/ovarian-prevention-pdq
PDQ Screening and Prevention Editorial Board. (2025d). Endometrial cancer screening (PDQ®)–Health professional version. National Cancer Institute. https://www.cancer.gov/types/uterine/hp/endometrial-screening-pdq
PDQ Adult Treatment Editorial Board. (2025). Endometrial cancer treatment (PDQ®)–Health professional version. National Cancer Institute. https://www.cancer.gov/types/uterine/hp/endometrial-treatment-pdq
T.C. Sağlık Bakanlığı Afyonkarahisar İl Sağlık Müdürlüğü. (2020, 22 Aralık). Kanser taramaları algoritmaları. https://afyonism.saglik.gov.tr/TR-102100/kanser-taramalari-algoritmalari.html
T.C. Sağlık Bakanlığı. (2026, 2 Ocak). Serviks kanseri. https://honazdh.saglik.gov.tr/TR-1406455/serviks-kanseri.html
T.C. Sağlık Bakanlığı Aydın İl Sağlık Müdürlüğü. (2025, 28 Ocak). Kanser Erken Teşhis, Tarama ve Eğitim Merkezleri (KETEM). https://aydinism.saglik.gov.tr/TR-35051/kanser-erken-teshis-tarama-egitim-merkezleriketem.html
T.C. Sağlık Bakanlığı Osmaniye İl Sağlık Müdürlüğü. (2026, 6 Ocak). 1–31 Ocak Serviks Kanseri Farkındalık Ayı. https://osmaniyeism.saglik.gov.tr/TR-371532/1-31-ocak-serviks-kanseri-farkindalik-ayi.html
World Health Organization. (2007). Cancer control: Knowledge into action: WHO guide for effective programmes—Prevention. https://www.who.int/publications/i/item/cancer-control-prevention
World Health Organization. (2014). Comprehensive cervical cancer control: A guide to essential practice (2nd ed.). https://www.who.int/publications/i/item/9789241548953
World Health Organization. (2017). Guide to cancer early diagnosis. https://www.who.int/publications/i/item/guide-to-cancer-early-diagnosis
World Health Organization. (2020). Global strategy to accelerate the elimination of cervical cancer as a public health problem. https://www.who.int/publications/i/item/9789240014107
World Health Organization. (2021). WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention (2nd ed.). https://www.who.int/publications/i/item/9789240030824
World Health Organization. (2022). Human papillomavirus vaccines: WHO position paper, December 2022. Weekly Epidemiological Record, 97(50), 645–672. https://www.who.int/publications/i/item/who-wer9750-645-672
World Health Organization. (2023). Policy brief on integrating rehabilitation into palliative care services. WHO Regional Office for Europe. https://www.who.int/europe/publications/i/item/WHO-EURO-2023-5825-45590-68173
World Health Organization. (2026a, July 3). Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer
World Health Organization. (2026b). Global status report on cancer 2026: The future we choose together. https://www.who.int/publications/i/item/9789240123977
World Health Organization. (2026c). WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: Use of human papillomavirus DNA genotyping. https://www.who.int/publications/i/item/9789240121744
World Health Organization. (2026d). Screening for cervical cancer. https://www.who.int/activities/screening-for-cervical-cancer/screening-for-cervical-cancer
World Health Organization. (2026e). Evidence-informed guidance for the implementation of HPV-based cervical cancer screening programmes. https://www.who.int/publications/b/83466
World Health Organization. (2026f). Controlling cancer. https://www.who.int/activities/controlling-cancer
ÜNAL, A. & YILMAZ, A. N. (2026). JİNEKOLOJİK KANSERLERDE GÜNCEL TARAMA YAKLAŞIMLARI VE ERKEN TANI. In GÜÇLÜ CİHAN, E. (Ed.), Kadın Sağlığında Güncel Yaklaşımlar ve Disiplinlerarası Perspektifler (pp. 234-255). Vizetek Yayıncılık. https://doi.org/10.54637/vizetek.9786253824013
| Kitap: |
| Yayınevi:
Vizetek Yayıncılık |